Jefferies Group’s Filana Therapeutics FLNA Stock Holding History

Jefferies Group’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.45M	Sell	34,753 -24,310	-41%	-$657K	0.01%	703
2022 Q2	$1.66M	Buy	+59,063	New	+$1.49M	0.01%	663
2021 Q3	–	Sell	-11,865	Closed	-$990K	–	1979
2021 Q2	$1.01M	Sell	11,865 -1,135	-9%	-$60.8K	0.01%	988
2021 Q1	$584K	Sell	13,000 -112,000	-90%	-$4.4M	0.01%	1082
2020 Q4	$853K	Buy	125,000 +25,000	+25%	+$223K	0.01%	992
2020 Q3	$1.15M	Hold	100,000	–	–	0.01%	754
2020 Q2	$308	Buy	100,000 +20,000	+25%	+$90.7K	﹤0.01%	1007
2020 Q1	$329K	Buy	80,000 +10,000	+14%	+$66.2K	﹤0.01%	1498
2019 Q4	$364K	Buy	+70,000	New	+$121K	﹤0.01%	1985

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Group's FLNA Position: Q3 2022 in Review

Jefferies Group reduced its Filana Therapeutics (FLNA) stake by 41% in Q3 2022, selling an estimated $657K and leaving 34,753 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #703.

Jefferies Group first reported a position in FLNA in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.66M in Q2 2022. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

Jefferies Group held 34,753 shares of Filana Therapeutics worth $1.45M as of Q3 2022.
Jefferies Group sold 24,310 Filana Therapeutics shares in Q3 2022, an estimated $657K.
Filana Therapeutics made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #703 holding.
Jefferies Group first reported a position in Filana Therapeutics in Q4 2019 and has held it in 9 quarters since.
Jefferies Group's Filana Therapeutics position peaked at $1.66M in Q2 2022.
175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.